Fig. 6
From: BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
Kaplan–Meier survival curve of effect of BRAF V600E mutation status on disease recurrence–free probability in patients with papillary thyroid cancer. Comparison of recurrence-free survival of patients, represented by indicated log-rank and P values in the panel, was performed between BRAF mutation and wild type groups. Follow-up time truncated at 6 years